Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 on the page displaying a 403 error.SummaryDifference0.2%

- Check10 days agoChange DetectedA banner announces an NIH website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check17 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check24 days agoChange DetectedThe revision label in the site footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the full content, showing a minimal error layout with the site header and footer. This indicates blocked access to the page and a shift away from the previous study-related content and links.SummaryDifference20%

- Check45 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0. This reflects an updated document or protocol version associated with the study page.SummaryDifference0.0%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.